Top 50 Medical Device VC Funds & Investors (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Innova Memphis
VC Fund
|
71 | United States, Argentina, United Kingdom | Seed, Pre-Seed | Health Care, Medical, Medical Device | $25k–$1.7M |
|
SOSV
VC Fund
|
58 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Enterprise Ireland
VC Fund
|
38 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $494k–$12M |
|
Zürcher Kantonal Bank
VC Fund
|
25 | Switzerland, Germany, Japan | Seed, Series A | Health Care, Medical Device, Biotechnology | $1.2M–$14M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
24 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $909k–$40M |
|
Bpifrance
VC Fund
|
24 | France, United States, Switzerland | Seed, Series A | Software, Information Technology, Health Care | $713k–$34M |
|
Broadview Ventures
VC Fund
|
24 | United States, Switzerland, Canada | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $1M–$45M |
|
Parkwalk Advisors
VC Fund
|
22 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $982k–$46M |
|
Portfolia
VC Fund
|
21 | United States, Canada, Argentina | Seed, Series A, Series B | Health Care, Biotechnology, Software | $347k–$59M |
|
TEDCO
VC Fund
|
21 | United States, Canada, United Kingdom | Seed, Grant, Pre-Seed | Health Care, Software, Biotechnology | $25k–$2.5M |
|
HealthTech Capital
VC Fund
|
19 | United States, Canada | Seed, Series A, Convertible Note | Health Care, Medical Device, Medical | $1M–$15M |
|
Sofinnova Partners
VC Fund
|
19 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$102M |
|
Western Development Commission
VC Fund
|
18 | Ireland, United States | Seed, Series A | Health Care, Medical Device, Biotechnology | $642k–$11M |
|
Khosla Ventures
VC Fund
|
18 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care | $2M–$100M |
|
Alumni Ventures
VC Fund
|
17 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.4M–$86M |
|
CincyTech
VC Fund
|
17 | United States | Seed, Series A, Series B | Software, Health Care, Biotechnology | $250k–$30M |
|
New York Angels
VC Fund
|
17 | United States, Israel, United Kingdom | Seed, Series A, Series B | Software, Health Care, Mobile | $500k–$19M |
|
Connecticut Innovations
VC Fund
|
17 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $200k–$25M |
|
North Coast Ventures
VC Fund
|
16 | United States | Series A, Seed | Health Care, Software, Medical Device | $350k–$10M |
|
Archangels
VC Fund
|
16 | United Kingdom, United States | Seed, Series A | Software, Biotechnology, Health Care | $1.3M–$8.3M |
|
Oxford Finance LLC
VC Fund
|
16 | United States, United Kingdom, Canada | Debt Financing, Post-IPO Debt, Series B | Biotechnology, Health Care, Medical | $5M–$150M |
|
MB Venture Partners
VC Fund
|
16 | United States, Israel | Seed, Series B, Series C | Health Care, Medical, Medical Device | $50k–$28M |
|
Wavemaker 360
VC Fund
|
16 | United States, United Kingdom, Canada | Seed, Series A | Health Care, Medical, Medical Device | $700k–$16M |
|
Boston Harbor Angels
VC Fund
|
16 | United States, Canada, India | Angel, Seed, Series A | Biotechnology, Health Care, Medical Device | $100k–$6M |
|
EIT Health
VC Fund
|
16 | United Kingdom, Spain, Ireland | Grant, Pre-Seed, Seed | Health Care, Medical Device, Medical | $22k–$1.6M |
|
Gaingels
VC Fund
|
16 | United States, Canada, Mexico | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1.5M–$100M |
|
Versant Ventures
VC Fund
|
15 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.7M–$108M |
|
SFC Capital
VC Fund
|
15 | United Kingdom, United States, Canada | Pre-Seed, Seed | Software, Artificial Intelligence, Information Technology | $159k–$2.2M |
|
Texas HALO Fund
VC Fund
|
15 | United States, Canada, Hungary | Seed, Convertible Note, Series A | Health Care, Medical Device, Software | $105k–$10M |
|
Scottish Enterprise
VC Fund
|
15 | United Kingdom, United States, Japan | Grant, Seed | Biotechnology, Software, Health Care | $124k–$4.8M |
|
Maine Angels
VC Fund
|
15 | United States | Seed, Series A | Health Care, Software, Biotechnology | $25k–$5.9M |
|
Qiming Venture Partners
VC Fund
|
15 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5M–$142M |
|
Arboretum Ventures
VC Fund
|
15 | United States, Canada, Israel | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $4.4M–$80M |
|
Development Bank of Wales
VC Fund
|
14 | United Kingdom, Australia, United States | Seed, Debt Financing | Software, Health Care, Biotechnology | $18k–$3.7M |
|
Irrus Investments
VC Fund
|
14 | Ireland, Sweden, United States | Seed, Series A | Health Care, Medical Device, Biotechnology | $713k–$8.8M |
|
Society for Innovation and Entrepreneurship
VC Fund
|
14 | India | Seed | Manufacturing | $3k–$715k |
|
Good Growth Capital
VC Fund
|
14 | United States, France, Israel | Seed, Series A, Convertible Note | Health Care, Biotechnology, Software | $25k–$24M |
|
Foundation for Innovation and Technology (FIT)
VC Fund
|
14 | Switzerland, France | Debt Financing, Grant, Seed | Health Care, Biotechnology, Information Technology | $23k–$1.2M |
|
Mercia Fund Managers
VC Fund
|
14 | United Kingdom, United States, Hungary | Seed, Series A | Software, Health Care, Biotechnology | $196k–$14M |
|
Keiretsu Forum
VC Fund
|
13 | United States, India, Turkey | Seed, Series A | Health Care, Software, Biotechnology | $102k–$8.6M |
|
Silicon Valley Bank
VC Fund
|
13 | United States, United Kingdom, Canada | Debt Financing, Series B, Series A | Software, Health Care, Biotechnology | $3.3M–$130M |
|
Verve Ventures
VC Fund
|
13 | Switzerland, Germany, France | Series A, Seed, Series B | Health Care, Software, Biotechnology | $1.4M–$43M |
|
Life Science Angels
VC Fund
|
13 | United States, Israel, The Netherlands | Seed, Series A | Biotechnology, Health Care, Medical | $1M–$20M |
|
Cowin Capital
VC Fund
|
13 | China, Hong Kong, United States | Series A, Series B, Seed | Manufacturing, Health Care, Biotechnology | $1.4M–$50M |
|
Catalyst Health Ventures
VC Fund
|
13 | United States | Series B, Series A, Series C | Health Care, Medical Device, Medical | $1.3M–$85M |
|
GO CAPITAL
VC Fund
|
13 | France, Canada, Israel | Seed, Series A | Biotechnology, Software, Health Care | $516k–$10M |
|
Oxford Bioscience Partners
VC Fund
|
13 | United States, Germany, Switzerland | Series B, Series C, Series A | Health Care, Biotechnology, Pharmaceutical | |
|
HSG
VC Fund
|
13 | China, United States, Hong Kong | Series A, Series B, Series C | Health Care, Biotechnology, Software | $4.4M–$214M |
|
Horizon Technology Finance
VC Fund
|
13 | United States, Canada, India | Debt Financing, Post-IPO Debt | Health Care, Biotechnology, Medical Device | $5M–$40M |
|
Ben Franklin Technology Partners of Southeastern Pennsylvania
VC Fund
|
13 | United States | Seed, Grant, Debt Financing | Health Care, Software, Information Technology | $5k–$2.2M |
| Access all 8146 VC funds in Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: United States, Argentina, United Kingdom
Investor stats
- Total investments: 251
- Round size: Seed $50k–$1.7M; Pre-Seed $25k–$1.3M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- HerdDogg — HerdDogg is passionate about livestock. Its innovative data platform sits at the intersection of agtech, the internet of things, and global food security. Our patented DoggTags and DoggBone, together with our Animal Traceability Platform, help producers make more money from every animal they raise. The HerdDogg system enables animal tracking,welfare monitoring and traceability in an easy-to-use application. For more information, visit herddogg.com.
- Insignum AgTech — Insignum AgTech develops biotech plants that communicate with producers, alerting them to an illness in its early stages.
- Rescue Forensics — Customer service is our #1 priority. Get a premium domain for your website today. Financing available.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 495
- Round size: Seed $494k–$3.3M; Series A $2.2M–$12M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $1.1M in 2021
Portfolio highlights
- Tirlan — Tirlan is an agricultural company that supplies agri-food and farm input materials to the framing sector.
- Lakeland Dairies — Lakeland Dairies, a major dairy processing co-operative, operates within a fifteen county catchment area across the northern half of the island of Ireland. The Group processes about one billion litres of quality milk annually into a range of value added dairy foodservice products and functional dairy food ingredients.
- Digital Learning Institute — Become a certified digital learning professional with globally recognized, industry-approved instructional design courses at Digital Learning Institute.
Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Switzerland, Germany, Japan
Investor stats
- Total investments: 182
- Round size: Seed $1.2M–$5.8M; Series A $2.3M–$14M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- TestResults — TestResults uses the TrueTest technology and AI-based virtual user that makes it possible for the first time to test autonomously across software, system, and technology boundaries from a user perspective with the same approach. The company has simplified automated testing massively and reduced time radically. With it, the automation andmaintenance effort is reduced to a minimum that allows zero flakiness and the enlightening feeling of being in control of automation and test scenarios.
- QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
- Pearltec AG — Headquartered in Schlieren / Zurich, Pearltec AG develops, produces and delivers solutions for the optimal storage, fixation and positioning of patients. Their products are based on unique, patented technology developed in collaboration with ETH Zurich and renowned university hospitals.They have set theirselves the goal to use the technologycompetence of Pearltec AG for the benefit of humans, animals and industry and to create added value for their customers by excellent quality and convincing application advantages.Pearltec AG is certified according to ISO standard 13485. This certification certifies that their quality management system for the development and manufacture of medical devices meets the highest international standards.
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 550
- Round size: Seed $909k–$7.7M; Series A $3M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- Samp — Whatever the scale, age, or number of facilities, Shared Reality helps industrial operators accelerate their digital twin programs in an affordable and accessible way.
- FinMarie — FinMarie is an online financial platform for women for women in Germany. The firm supports clients with financial and wealth management projects and helps them find solutions appropriate for their personal situation.
- GeneQuine Biotherapeutics — GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 1039
- Round size: Seed $713k–$6.9M; Series A $2.6M–$34M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Hiqute Diamond — High quality diamond plates for high-end applications
- Pitchy — Create professional videos without technical expertise. Our online video editor helps you easily make business videos.
- Siteflow — For many years digital transformation of the manufacturing industry has been underway. However, for regulated industries and operations that combine complex reporting workflows, project manufacturing and mobility for the field, few digital solutions meet the expectations. As a result, on those sites, tools and work methods haven’t changed so muchthe past decades while quality and safety requirements have exploded.That is around those challenges that professionnals from the nuclear industry, special works and software experts have gathered, to create Siteflow, the first cloud-based field service management software designed for complex operations (Nuclear, Oil&Gas…).A solution designed for end-userBeyond technical specificities from those markets, we have leveraged learnings from industries that have already been through digital transformation: every time user acceptance is key to make those challenging projects a success.This is why at Siteflow, our obsession is to design the most simple interfaces, and functionalities that bring value directly for our users, in order to simplify their daily tasks, to ease collaboration with their colleagues and to help them focus on what really matters.A change management program to facilitate digital transformationAs we all know, the choice of a software solution is just part of the puzzle to implement a digital transformation program. Organizations need to be re-designed as day-to-day activities of engineers, project managers and operators are directly concerned. Based upon our experience, we help our customers for a smooth transition to operational excellence.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 77
- Round size: Seed $1M–$9.8M; Series A $1M–$30M; Series B $7M–$45M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- FineHeart — Our mission is to address the unmet need of patients with sever heart failure
- 480 Biomedical — 480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery (SFA). Its lead product, SFA scaffold, is a proprietary scaffold and delivery system for use in treating peripheral arterial disease in the SFA. The company was founded in 2011 and is based in Watertown,Massachusetts.
- Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 258
- Round size: Seed $982k–$4.7M; Series A $1.6M–$13M; Series B $2M–$46M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
- Bramble Energy — Bramble Energy is an innovator energy technology company that designs and manufactures high-performance, low-cost, and fuel cell stack. The company ability to leverage the global high-volume PCB industry means that they are the first fuel cell company with the manufacturing capacity to supply gigawatts of fuel cell hardware, something the batteryindustry has spent many years and £B’s to achieve.Bramble Energy specifically uses a printed circuit board (PCB) technology to form the structural parts of the fuel cell. It also provides products including modular PCBFC stacks, H20:20W PCBFC system, custom design PCBFC, and 500W PCBFC stack.Bramble Energy was founded in 2016 and is based in London, England, United Kingdom.
- Echion Technologies — Echion Technologies is a spinout from the University of Cambridge Engineering Department, using proprietary battery active materials to develop next-generation Li-ion batteries.
Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Argentina
Investor stats
- Total investments: 180
- Round size: Seed $1.3M–$4.3M; Series A $347k–$15M; Series B $9M–$59M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $722k in 2022
Portfolio highlights
- Future Family — Our loans for IVF & egg freezing make it easy for you to get started quickly with fertility treatment. Learn more about our Fertility Financing & Loans today!
- UnaliWear — The Kanega Watch is a wearable medical alert device and fall detection watch with voice activated help that you never have to remove to charge.
- Sandstone Diagnostics — Sandstone's Torq technology enables point-of-care clinical diagnostics and care by bringing the sample prep to the patient.
TEDCO is an independent organization that strives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Grant, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 247
- Round size: Seed $100k–$2.5M; Grant $25k–$1M; Pre-Seed $25k–$900k
- Lead/follow: 65% lead, 35% follow
Portfolio highlights
- OmniSpeech — OmniSpeech develops AI-powered speech processing software that eliminates noise and improves voice intelligibility.
- Digital Harbor Foundation — Digital Harbor Foundation is comprised of people who love what they do and work hard day-in and day-out to make a difference in the lives of the youth they serve. They think hard about education, technology, and innovation, and work even harder to overcome the socio-economic barriers that impede forward progress for too many. They are not perfectbut they care about their work and give it everything they have every day.
- Howard County Library System — Howard County Library System is a public library systems that aims to deliver high-quality public education for all ages.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Private angel investors and corporate venture ecosystem investing in healthtech, digital health and other healthcare technologies startups
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A, Convertible Note
- Geography: United States, Canada
Investor stats
- Total investments: 94
- Round size: Seed $1M–$3.4M; Series A $1.6M–$15M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- S2 Genomics — S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications. It enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies. The company's vision is to provide products that process raw tissues into samples ready for genomicanalyses.S2 Genomics was founded in 2016 and is headquartered in Livermore, CA.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
- GT Metabolic Solutions — GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 298
- Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
- Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 43
- Round size: Seed $642k–$3.7M; Series A $2.2M–$11M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
- Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1075
- Round size: Seed $2M–$16M; Series A $5.5M–$44M; Series B $10M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $557M in 2022
Portfolio highlights
- Loop — Loop Health is bringing ease and choice to patients seeking major medical treatments. We've brought together family physicians, top specialists, and leading hospitals in Pune – to provide options, transparency, and ease to patients and their families. Loop Coordinators help patients match with a doctor, compare treatment costs, get secondopinions, and complete admission formalities – removing the stress and making lives easier for the patient and their families.
- Siolta Therapeutics — Siolta Therapeutics is harnessing science from the human microbiome to design next-generation microbial therapeutics. Learn more.
- Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 1413
- Round size: Seed $1.4M–$10M; Series A $5.2M–$37M; Series B $12M–$86M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Polygraf — AI Usage Behavioral Control Layer - Polygraf sits directly between enterprise users, agents, and AI systems to inspect every AI interaction before data leaves your security boundary.
- Operant — Own OperantAi.com today. Secure checkout and guided transfer support. No hidden fees.
- Arda Therapeutics — Arda Therapeutics is a biotechnology company taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions. Their approach starts by using single-cell data to identify pathogenic cells and specific markers to target them. They then design therapies to eliminate these - and only these - cells.Arda wasfounded in 2021 in the San Francisco Bay Area, CA.
CincyTech helps to identify and transform innovation into venture-worthy, transformational human health and technology companies, primarily in southwest Ohio. Our team provides advice and capital to entrepreneurs, helps research institutions commercialize technology through startups, and catalyzes investment from individuals and institutions intoregional companies. One of the most active seed funds in the Midwest, CincyTech is supported by Ohio Third Frontier, more than two dozen foundations, corporations, municipalities and individuals as well as founding partners, Cincinnati Children’s Hospital Medical Center, the University of Cincinnati, and the Cincinnati USA Regional Chamber.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 120
- Round size: Seed $250k–$3.5M; Series A $300k–$30M; Series B $2.5M–$11M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $12M in 2023
Portfolio highlights
- Amify — We help brands selling on Amazon maximize sales and profitability by providing complete strategy, management and operational services.
- Invirsa — Invirsa is developing a unique, broad platform based on a naturally occurring small molecule (INV-102) that has demonstrated enhanced immune response to infection. INV-102 not only reduces viral infection, and potentially bacterial replication, it also reduces inflammation, while enhancing the bodies wound healing response. Invirsa'stechnology is first being developed in the ophthalmology and pulmonary space.Invirsa’s technology has the potential to be a first line therapy for common infectious diseases, whether it's the 100 million viral pulmonary infections or the 5 million infectious conjunctivitis cases that occur every year in the US alone.
- TeamCentral — TeamCentral is a company focused on optimizing productivity through improvements in how data is managed and governed across business systems.
New York Angels is one of the oldest, most prominent angel investment groups in the country. New York Angels has offered early-stage entrepreneurs funding, mentoring, connections and more for over 20 years. Angel investors join New York Angels for their extensive, experienced network, increased de
Show more...Investment focus
- Industry: Software, Health Care, Mobile
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 198
- Round size: Seed $500k–$5M; Series A $1.2M–$8.1M; Series B $2M–$19M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $1.2M in 2012
Portfolio highlights
- Dstlry — DSTLRY is the next-generation comics publisher and it redefines creator-owned comic books for consumers everywhere.
- MAVI.io — Discover Mavi.io OnMyWay Commerce, the trailblazing in-car commerce marketplace transforming the world of automotive, retail an and payments. Explore our innovative solutions designed to enhance your driving experience and streamline on-the-go transactions. Join us as we drive the future of commerce
- Solidec — Solidec is the pathway to emission-free compounds, beginning with hydrogen peroxide.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 246
- Round size: Seed $200k–$5M; Series A $2.4M–$25M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- Device42 — Device42 sets the standard as the most comprehensive, agentless discovery and dependency mapping solution, spanning from legacy mainframes to cloud containers.
- Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
- NovaTract Surgical — NovaTract Surgical is a development stage company, intends to develop medical devices to address the rapidly growing field of Single Incision Laparoscopic Surgery (SILS) and Natural Orifice Transluminal Endoscopic Surgery (NOTES). The company was incorporated in 2010 and is based in Guilford, Connecticut.
North Coast Ventures (formerly North Coast Angel Fund) is comprised of four contributed capital funds with a focus on early-stage technology investments. Our membership consists of a number of Ohio's leading investors, entrepreneurs, and business leaders who are dedicated to accelerating early-stage ventures.North Coast Ventures members playan active role by generating deal flow, serving on due diligence teams, working with portfolio companies, or serving on the Investment Screening and Executive Committees. Through this involvement, our goal is to provide a supportive environment for our portfolio companies and ultimately enhance the performance of our Fund.Northeast Ohio has a long tradition of active and successful angel investing, but until recently, the success of this crucial form of funding has hinged on the efforts of a relatively small number of individual investors. As the region’s first professionally managed angel fund, North Coast Angel Fund works to improve the early-stage funding environment for both entrepreneurs and investors.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Series A, Seed
- Geography: United States
Investor stats
- Total investments: 99
- Round size: Seed $350k–$5.5M; Series A $1.2M–$10M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Primum —
- InnerActiv — InnerActiv is a cybersecurity software company that protects organizations from insider threats, fraud, and data loss at the endpoint. Built with an AI-driven, behavior-based approach, InnerActiv delivers real-time visibility into how users interact with sensitive data, systems, and devices—detecting risky activity such as data grazing, policytesting, and low-and-slow reconnaissance before it leads to a breach. The platform’s lightweight, encrypted agents and endpoint-first design provide proactive protection, faster response, and seamless integration with existing security stacks.
- TandemStride — TandemStride provides genuine, individualized support to survivors and their loved ones, whether in the form of a peer mentor with training, resources, or just someone who knows what it's like to be in recovery.
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 84
- Round size: Seed $1.3M–$3.9M; Series A $1.6M–$8.3M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- 1inhaler — 1inhaler operates as a developer of drug delivery device.
- BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
- Cytomos — Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Providing Flexible and Creative Financial Solutions to Middle Market Companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Debt Financing, Post-IPO Debt, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 119
- Round size: Series B $39M–$76M; Post-IPO Debt $15M–$150M; Debt Financing $5M–$75M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Inhibrx — Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The Inhibrx pipeline is focused on oncology,orphan diseases and infectious diseases. Inhibrx has collaborations with Celgene and bluebird bio and has received awards from several granting agencies, including NIH, NIAID and CARB-X.
- Vortexa — State of the art energy analytics that paints a global picture of cargo flows. Identify energy market opportunities before the competition with Vortexa.
- Celcuity — Celcuity is a clinical-stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic platform, CELsignia, analyzes living tumor cells to untangle the complexity of the cellular activity driving apatient's cancer. This allows Celcuity to discover new cancer sub-types molecular diagnostics cannot detect. Celcuity is driven to improve outcomes for patients and to transform how pharmaceutical companies define the patient populations for their targeted therapies.
MB Venture Partners in Memphis, TN provides venture capital for life sciences: medical device, biotechnology companies, products for musculoskeletal diseases
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series B, Series C
- Geography: United States, Israel
Investor stats
- Total investments: 90
- Round size: Seed $50k–$700k; Series B $1.3M–$18M; Series C $5M–$28M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $22M in 2011
Portfolio highlights
- Cast21 — The future of orthopedic technology has arrived. Cast21 braces are designed for your active lifestyle.
- SweetBio — SweetBio is a Memphis, Tennessee based medical device company specializing in bioengineering honey-incorporated materials for wound care.
- Lineus Medical — Lineus Medical is a medical device company focused on reducing IV complications for patients and providers all over the world.
Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 77
- Round size: Seed $700k–$6M; Series A $1.9M–$16M
- Lead/follow: 13% lead, 87% follow
- Last fund: Likely still investing — raised $64M in 2022
Portfolio highlights
- FreeNav, Inc. — FreeNav is simplifying and standardizing the position tracking of procedural instrumentation for medical applications and procedures.
- Hermes Health — Big IdeaHermes Health is a secure, neutral middleware platform that simplifies and standardizes access to identified patient health data. We connect Requestors (e.g., attorneys, CROs, analytics firms) with Partners (e.g., ROI vendors, EHR providers, RWD sources) who hold and manage this data.ProblemAccessing identified health data remainslargely manual and outdated—relying on phone calls, faxes, and mailed records. This process is fragmented, costly, and inefficient. Requestors face a maze of disconnected workflows, while Partners are bogged down by inconsistent standards and manual tasks.SolutionHermes Health offers a scalable API and the Unity Platform to power secure, patient-consented data workflows. We reduce integration complexity and contractual friction by enabling seamless connectivity between Requestors and our network of Partners.The Unity Platform integrates with Partners as they are—plugging into existing APIs or co-developing new ones to match their systems. Whether you're a requestor or a data custodian, Hermes Health accelerates access while preserving security and compliance.
- Esperto Medical — Esperto Medical is an Irvine, CA-based medical device company developing next-generation wearable diagnostics that enable hospital-based and remote patient monitoring with unprecedented ease and accuracy. Its unique resonance sonomanometry technology uses acoustic stimulation to directly and noninvasively measure continuous blood pressure withoutcalibration.
Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high growth, early stage companies. The group was formed in February 2004 and since then has made a number of investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation,etc. They believe they contribute more than money to the companies they fund and welcome the opportunity to work with entrepreneurs open to take advice, yet having the smarts and determination to make the company successful.Their focus is on early stage companies usually looking to raise $250K to $1.5M, where they can fund a portion of the round and syndicate the deal with other angel groups or early stage venture funds. The stage of the company should be close to commercialization, while the company should have a clear and defensible competitive advantage. They are looking for capital efficient businesses, which can reach profitability with less than $5M of equity investment and provide at least 10X return on the investment within 5 years.They do not invest as a fund - each of their members makes his or her individual investment decision but they collaborate in Due Diligence. They have a deep expertise in the life sciences field where they usually take the position of a lead investor, but are open to any opportunities that can make a strong business case. In some cases they prefer to be the follow on investor if they cannot identify a person with strong expertise within their group.The group’s strategy is directed by an executive committee which consists of 8 people elected by the group: Wayne Griffith (chairman), Bill McPhee, Henry Kay, Jay Schwartz (membership director), Steve Andress, Peter Miller, Don Freeman and Mic Williams (president and founder). The group’s day-to-day operations are managed by Boris Batchvarov (managing director).They receive 20-30 business summaries each month, out of which they select 8 companies to make a personal presentation to their screening committee. The screening committee consists of volunteers from the group. The presentations are 10 min long followed by 10 min Q&A. 4 of the companies are invited to present to the whole group, with the idea to get the people interested and decide to perform a Due Diligence with the companies before making an investment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Angel, Seed, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 105
- Round size: Seed $100k–$2.4M; Angel $500k–$1.6M; Series A $662k–$6M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Zylö Therapeutics — Patented technology that enables, for topicals, sustained release, increased druggability, a Patchless Patch concept, and enhanced targeting of pores and follicles
- Xeno Biosciences — Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.It wasfounded in 2015 and is headquartered in Somerville, Massachusetts.
- Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, Spain, Ireland
Investor stats
- Total investments: 95
- Round size: Seed $220k–$1.4M; Grant $22k–$1.6M; Pre-Seed $44k–$1.4M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- IDOVEN — IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
- eBreathie — eBreathie is a pioneering digital health startup offering an integrated asthma management solution. Our system comprises a smart inhaler (a medical device) that not only tracks WHEN patients take their medication but also HOW they do it, creating a detailed inhalation profile for each use. Paired with a user-friendly mobile app for patients and acomprehensive patient management platform for doctors, we provide real-time feedback on inhalation efficacy, ensuring patients and healthcare professionals have the insights needed for optimal asthma management. Leveraging IoT and AI, our goal is to reduce emergency visits, asthma attacks, and hospitalizations while ensuring effective inhalation techniques and optimal patient care.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 728
- Round size: Seed $1.5M–$8M; Series A $6M–$40M; Series B $16M–$100M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- BQP — BosonQ Psi Pvt. Ltd. (BQP) is a state-of-the-art SaaS-based enterprise software venture leveraging the power of Quantum computing to speed up virtual simulations of Multiphysics and Computer-Aided Engineering (CAE) nature. BosonQ Psi is at the forefront of this quantum revolution. Our vision is to become the premier multiphysics simulation softwareusing quantum computing. Our world-class software suite will include computational science fields of fluid dynamics, structural dynamics, thermal, chemical, and aeroacoustics. With such an innovative product, we will revolutionize the computational world by enabling high-fidelity simulations that are impossible to solve with current computing technology. Further, this product will aid aerospace, automotive, energy, manufacturing, biotechnology, civil engineering, and astrophysics industries in saving millions of dollars by reducing long turnaround times of simulations used in the design process and give higher accuracy to make significant design changes for giving rise to the next generation of an electric car, eVTOL, skyscraper, or even Mars Rover.The possibility to harness the power of quantum computers is endless, and we at BQP thrive on pushing the boundaries of quantum computing technologies to serve our clients. We have made it our mission to bring these possibilities into the hands of every person - from a researcher to a scientist, from a professor to a student. Our name, BosonQ Psi, pays tribute to the great Indian physicist Dr. Satyendra Nath Bose, after whose name the elementary particle in quantum mechanics, Boson, was named and further incorporates the fundamental quantity that describes the state of the quantum particle - Psi, thus symbolizing the company's fundamental goal to contribute in India's goal to be the leader in the Quantum realm and also become a global leader in Quantum paradigm shift in coming years.
- BetterBrand — Designing a Better future of food. The Better Bagel features Fewer Carbs and More Protein.
- Sharper Sense — Neuromodulation for Clear Senses
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 280
- Round size: Series A $4.7M–$80M; Series B $10M–$105M; Series C $12M–$108M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
- Nested Therapeutics — Nested Therapeutics is a Cambridge-based VC-backed stealth biotech company. The company's focus is on finding and creating new precision oncology small-molecule drugs targeted toward cancer genes. Nested Therapeutics was established in 2021 in Cambridge, Massachusetts.
- Dualitas Therapeutics — Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders and other conditions. With a growing collection of innovative cell surface proximity engagers and our in-house DualScreen™ discovery engine, our pipeline
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 355
- Round size: Seed $164k–$2.2M; Pre-Seed $159k–$812k
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Elaitra — Elaitra’s breast cancer platform includes a Generative LLM for voice-based patient engagement, and a unique AI reading tool that helps doctors read 3D X-Rays. Operating in USA & UK. FDA 510(k) and UK regulator approved.
- Sages — Biodegradeable, non-polluting, low-impact and vibrant dyes extracted from food waste.
- JustTip — JustTip provides full-suite contactless tipping systems for the hospitality business. Sign up today to streamline your tipping system.
Early Stage Venture Investments
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Seed, Convertible Note, Series A
- Geography: United States, Canada, Hungary
Investor stats
- Total investments: 92
- Round size: Seed $105k–$3M; Series A $3M–$10M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $175k in 2021
Portfolio highlights
- Flourish Care — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
- Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
- Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed
- Geography: United Kingdom, United States, Japan
Investor stats
- Total investments: 306
- Round size: Seed $318k–$3.4M; Grant $124k–$4.8M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
- Incremental Group — Incremental Group provides software consultancy and analytics services to clients in oil and gas, financial services, and the public sector.
- Smart Green Shipping — smart green shipping alliance. economically, socially and environmentally superior shipping solutions.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Maine Angels they make investments with entrepreneurs with an emphasis on businesses.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A
- Geography: United States
Investor stats
- Total investments: 129
- Round size: Seed $25k–$1.2M; Series A $662k–$5.9M
- Lead/follow: 1% lead, 99% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Waku — Deliciously replenishing herbal tea with prebiotic powers and 0g of added sugar. Experience Sunrise on the Inside.
- HighByte — Architect your digital transformation with proven Industrial DataOps software from HighByte. Let's make your industrial data useful.
- Pumpspotting — connect over breastfeeding, milk, motherhood, and the best places to nurse and pump. nurse, pump, nourish, connect.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 730
- Round size: Series A $5M–$64M; Series B $10M–$100M; Series C $15M–$142M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $887M in 2023
Portfolio highlights
- Duet — Duet is a dating application helps you find meaningful relationships based on shared interests and experiences.
- Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
- SPEEDIANCE — Speediance specializes on smart self-serviced gym equipment. The company develops smart fitness equipment and an online platform to provide training guidance and courses about strength training, enabling individual users to connect with the workout community and have better home workout experiences.
For over 20 years we have been a successful healthcare venture capital firm rooted in the Midwest. Check out our portfolio companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 113
- Round size: Series A $4.4M–$27M; Series B $5M–$55M; Series C $10M–$80M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $250M in 2019
Portfolio highlights
- Endogenex — DyaMX is an early stage medical device company focused on the treatment of Type 2 Diabetes
- Allay Therapeutics — SUPPORTING PATIENTS THROUGH EVERY PHASE OF RECUPERATION The first technology designed to deliver weeks of localized pain management
- Reprieve Cardiovascular — Reprieve Cardiovascular is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Debt Financing
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 214
- Round size: Seed $327k–$3.7M; Debt Financing $18k–$3.7M
- Lead/follow: 59% lead, 41% follow
- Last fund: May invest from a new fund soon — raised $25M in 2018
Portfolio highlights
- Tourhub — tourhub - We collect tours from hundreds of suppliers around the world and provide an easy way for you to search and find those that are of interest.
- Bond Digital Health — Bond Digital Health is a technology company developing end-to-end digital connectivity for the point-of-care diagnostics market. Developed by founders Ian Bond and Dave Taylor and originally designed as a patient self-management tool, Bond’s digital technology was remodeled to meet the needs of a client - a world-renowned innovator in point-of-carediagnostics and the lateral flow industry. The client required a digital platform consisting of a patient-facing mobile app and cloud data management for their new quantitative diagnostic test for chronic lung disease. They shared their experiences of working with us with a collaborator company who quickly commissioned Bond to develop a similar product for chronic wound care. Others in the lateral flow industry recognised that an affordable, compliant and scalable solution was available highlighting a huge unmet need in an expanding market. Bond is working in strategic partnerships with key industry leaders to create the next generation of digitally connected lateral flow diagnostics that provide an elevated user experience and enhanced real-time decision-making through the power of data aggregation and data analytics.Our regulatory strategy ensures that the solutions we create are secure, reliable and compliant with regulatory standards, making us a trusted partner to leaders in human health, animal health and agri-food globally.In Bond Digital Health we believe that collaborative working is the only way to tackle some of the major health challenges the world is nowadays facing. Our technology brings the life sciences industry closer together to create solutions that improve the lives of millions.Let’s make a difference together!
- CoinCover — Cryptocurrency insurance-backed technology to make cryptocurrency safe for individuals and businesses to hold and use.
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, Sweden, United States
Investor stats
- Total investments: 34
- Round size: Seed $713k–$3.8M; Series A $2.2M–$8.8M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Bounce Insights — Bounce Insights is a digital consumer research platform. It provides a direct link between brands and any consumer they needed to speak to by maintaining a community of active, engaged respondents on their mobile app.
- Adama Innovations — Adama Innovations have a disruptive technology for advanced manufacturing. The company have developed a simple process for creating patterns, on a scale invisible to the human eye, on ultra-hard materials.The micro patterns can be applied to injection molds and forming dies used for the fabrication of medical devices, improving theircapability and reducing the cost of manufacture. Other applications include labelling and anti-counterfeiting technology.The company's first product is a nano-scale probe fabricated in diamond, for metrology applications in high-tech manufacturing.The company is a spin-out from CRANN, the flagship nanotechnology institute in Trinity College Dublin.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
SINE at IIT Bombay supports tech startups with incubation, mentorship, funding, and resources to turn innovative ideas into successful ventures.
Show more...Investment focus
- Industry: Manufacturing
- Stage:Seed
- Geography: India
Investor stats
- Total investments: 67
- Round size: Seed $3k–$715k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Endimension — Endimension develops AI solutions for medical image analysis. It helps to automatically detect abnormalities and diseases, via AI algorithms from medical scans, so as to reduce patient misdiagnosis and increase Radiologists’ efficiency.
- Torus Robotics — Torus Robotics develops unmanned ground vehicles, robotics, and innovative powertrain technology for defense, aviation, automotive, and consumer applications.
- Navork Innovations — Navork Innovations is an indian startup that provides technology for extending shelf life of fruits and vegetables that maintains freshness.
Good Growth Capital is an early-stage venture capital firm known for its expertise in finding, assessing and cultivating complex science and technology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Convertible Note
- Geography: United States, France, Israel
Investor stats
- Total investments: 111
- Round size: Seed $505k–$8.2M; Series A $4.2M–$24M; Convertible Note $25k–$300k
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $100M in 2023
Portfolio highlights
- Pryon — Pryon is the leading AI-as-a-Service platform for content and knowledge management. Pryon closes knowledge gaps, improving employee productivity, and enhancing customer experiences. Companies such as Georgia Pacific use Pryon to improve health and safety outcomes, eliminate compliance incidents, improve employee onboarding, and upgrade all aspectsof customer service and support.
- Obsidio — Obsidio™ Conformable Embolic with aqueous gel technology is a 510(k) cleared device, the first of its kind to have a specific on-label indication for peripheral use in the U.S.
- AdipoPharma — AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases.
The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Information Technology
- Stage:Debt Financing, Grant, Seed
- Geography: Switzerland, France
Investor stats
- Total investments: 155
- Round size: Seed $117k–$1.2M; Grant $23k–$125k; Debt Financing $63k–$583k
- Lead/follow: 93% lead, 7% follow
Portfolio highlights
- Phonemia — Phonemia is a digital health company that offers artificial intelligence and speech therapy services.
- MoleSense — Developing continuous molecular monitoring wearables to enable proactive healthcare.
- DiverSsiTy SA — DiverSsiTy SA develops personalized, patient-centric digital health technologies (DHTs) to improve the lives of patients suffering from neurodevelopmental disorders (NDDs), among which are those with autism spectrum disorder (ASD) and related comorbidities like attention-deficit/hyperactivity disorder (ADHD).
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 133
- Round size: Seed $196k–$2M; Series A $2M–$14M
- Lead/follow: 67% lead, 33% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- 4D Medicine —
- Adludio — Adludio is the AI-powered platform that delivers interactive mobile advertising. By using data to design your ad creative, and algorithms to optimize your campaigns, Adludio makes sure you win the battle for brand attention.
- OneUp Sales — OneUp Sales is a sales management & motivation platform built for inside sales teams. The platform makes use of sales activity data from any source to drive gamified competitions, real-time TV leaderboards, and streamlined reporting for managers.
Keiretsu Forum is a global angel investor network with more than 2,500 accredited investor members throughout 47 chapters on 3 continents.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A
- Geography: United States, India, Turkey
Investor stats
- Total investments: 187
- Round size: Seed $102k–$3.6M; Series A $778k–$8.6M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $10M in 2015
Portfolio highlights
- Bliss — Bliss is an AI-powered online therapy platform that provides online mental health and wellness services to make mental health support more accessible, affordable, and culturally sensitive. The company connects individuals with licensed therapists and mental health professionals for video, audio, and messaging-based counseling sessions. Its platformincludes therapist matching tools, secure communication systems, appointment scheduling, and multilingual support designed for users seeking culturally aligned care. Bliss supports mental health needs related to anxiety, depression, trauma, relationships, stress management, and personal development through remote therapy services. The company also offers mental wellness programs for businesses, providing employee support resources, coaching access, and digital mental health services for distributed teams. Its services are designed to make therapy and emotional support accessible through online and mobile-based interactions.
- AiM Medical Robotics — We Think in Real Time.
- Kisaan Se Kitchen Tak — Eat our pure, naturally grown, & direct farmse products, grown without use of harmful chemicals brought to directly from Kisaan Se Kitchen Tak; they'll fill your body with energy, nutrients, & antioxidants.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Silicon Valley Bank is the financial partner of the innovation economy; helping individuals and investors in the innovation ecosystem achieve extraordinary outcomes.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Series B, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 440
- Round size: Series A $5M–$30M; Series B $6M–$45M; Debt Financing $3.3M–$130M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- ShipBob — Ecommerce fulfillment for online stores. ShipBob empowers businesses to offer 2-day shipping and manage inventory, orders, and shipments.
- Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
- Viracta Therapeutics — Our team possesses deep, cross-functional experience and shares a longstanding commitment to developing new medicines to benefit cancer patients. Management Strategic Advisor Board of Directors Scientific Advisory Board
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 254
- Round size: Seed $1.4M–$10M; Series A $2.3M–$15M; Series B $4.2M–$43M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $66M in 2022
Portfolio highlights
- Kiutra — We provide cryogen-free cooling systems that simplify low-temperature research. Our solutions offer fast cooldowns, automated control and millikelvin performance ideal for quantum technologies and material science.
- iMusician — iMusician offers music distribution, promotion, mastering, and monetization for independent musicians & labels. Get on Spotify, Apple Music, Amazon, TikTok & many more.
- Clinpal — Backed by over 30 years of scientific discovery and validation, Cambridge Cognition offers the end-to-end platform for CNS clinical trials.
Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United States, Israel, The Netherlands
Investor stats
- Total investments: 85
- Round size: Seed $1M–$4M; Series A $1.3M–$20M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Flyte — Flyte promotes cellular healing in pelvic floor muscles for lasting results. Flyte is fast, proven, safe, pelvic floor therapy for bladder control.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
- Trio Pharmaceuticals — Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 266
- Round size: Seed $1.4M–$20M; Series A $4.3M–$43M; Series B $2.8M–$50M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $75M in 2014
Portfolio highlights
- Bytetree — Bytetree is a technology company that focuses on providing the one-stop AI data services for data collection, cleaning, labeling, management, and storage for OEMs and autonomous driving solution providers, covering bicycle intelligence. , vehicle-road coordination, and smart cockpit three scenarios.
- Cosminde — Cosminde is a developer of gastroenterology soft electronic endoscope products.
- Carbon Medtech — Carbon Medtech focuses on non-vascular procedures and offers surgical supplies and equipment.
Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of this strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Their disciplined investment process leverages bothintellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. By investing in solutions which have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation and consumer healthcare, we minimize the risks related to uncertain scientific experimentation.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series B, Series A, Series C
- Geography: United States
Investor stats
- Total investments: 46
- Round size: Series A $1.4M–$19M; Series B $2.3M–$33M; Series C $1.3M–$85M
- Lead/follow: 52% lead, 48% follow
- Last fund: May invest from a new fund soon — raised $75M in 2019
Portfolio highlights
- Lena Health — Lena is a virtual health assistant that takes care of all tasks to stay on top of the care plan, so you can sit back and focus on the things that matter to you.
- Venova Medical — Venova Medical, Inc. is a privately held company addressing the challenges associated with providing optimal vascular access for patients that need hemodialysis.
- Esperto Medical — Esperto Medical is an Irvine, CA-based medical device company developing next-generation wearable diagnostics that enable hospital-based and remote patient monitoring with unprecedented ease and accuracy. Its unique resonance sonomanometry technology uses acoustic stimulation to directly and noninvasively measure continuous blood pressure withoutcalibration.
GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Series A
- Geography: France, Canada, Israel
Investor stats
- Total investments: 132
- Round size: Seed $516k–$6.6M; Series A $2.1M–$10M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Episto — Episto helps you collect ultra-authentic insights from your targets, anywhere in the world, simply and instantly
- AISPRID — AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.
- Axomove — Axomove is an e-health app that specializes in video physical exercises.
BIGSLOT288 menghadirkan situs slot online dengan modal sepuluh ribu rupiah saja bisa menghasilkan jutaan dan bisa menikmatin bonus pendatang baru 100% di depan.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Series B, Series C, Series A
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 109
- Lead/follow: no public data
Portfolio highlights
- Paperspace — Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks. The Company’s large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomasssorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has sold switchgrass and high biomass sorghum seeds in the United States under its Blade Energy Crops (Blade) brand. In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda.
- CardioFocus — CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, andinvestigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias.CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.
- Yolia Health — Yolia Health developed The True Vision Treatment or TVT, the 'Invisalign' for the eyes. A non-invasive treatment to correct vision problems like presbyopia without surgery. TVT is self-administered by the patient in his or her own home. It employs a combination of customized contact lenses (TVT Contacts) and specially formulatedeye drops (TVT Eye Drops). After only 5 days of treatment with TVT patients are able to stop using the TVT Contacts, TVT Eye Drops and their reading glasses for up to 12 months at a time before re-treatment with TVT is needed. What is even greater than correcting for presbyopia non-invasively, is correcting both eyes without compromising any distance vision. On the contrary, Yolia's treatment improves both near and distance vision, a unique feature no single other alternative can provide. ** Looking for sophisticated investors and key industry partners.
We help founders build enduring companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 751
- Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
- Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
- Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billionin venture loans to thousands of companies.The company was founded in 2003 and is headquartered in Farmington, Connecticut.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Debt Financing, Post-IPO Debt
- Geography: United States, Canada, India
Investor stats
- Total investments: 104
- Round size: Post-IPO Debt $10M–$40M; Debt Financing $5M–$30M
- Lead/follow: 69% lead, 31% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- SparkCharge — SparkCharge is a company dedicated to making EV ownership easy by creating Charging as a Service, a convenient way for drivers to have their electric vehicles charged. They have created the world's first and only portable, ultra-fast EV charging system called the Roadie. They have also created BoostEV.
- Stellar Cyber — Stellar Cyber: Automation-Driven, Open & Unified SecOps Platform with AI SIEM, NDR, Open XDR, and Multi-Layer AI.
- Hyperfine — Hyperfine makes MRI accessible to every patient regardless of income or resources.
We’re (not just) investors.We’re (more than) advisors.We’re (beyond) connectors.Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives. For over 30 years, Ben has been the leading seedstage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Grant, Debt Financing
- Geography: United States
Investor stats
- Total investments: 137
- Round size: Seed $100k–$2.2M; Grant $5k–$100k; Debt Financing $975k–$975k
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
- SFA Therapeutics — SFA Therapeutics is developing a next-generation oral immune tolerance therapy for psoriasis. Our investigational approach is designed to restore immune tolerance at its source, targeting the underlying immune dysfunction rather than broadly suppressing the immune system. Supported by early human results, our platform aims to deliver a more precise, patient-friendly treatment option for chronic inflammatory disease.
- Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
Medical Device VC funding at a glance
Stats across 12k deals from 8.1k investors.
Access all 8146 VC funds in Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 8146 VC funds investing in Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!